University of California

Bright Uro is an early-stage medical technology company focused on developing innovative diagnostic devices specifically for urology. The company is creating a cutting-edge urodynamics system that integrates advanced hardware, software, and data science to deliver wireless, catheter-free urodynamics. This approach aims to enhance accuracy and comfort in the diagnosis and treatment of lower urinary tract symptoms and diseases. By providing clinicians with actionable insights, Bright Uro seeks to fundamentally improve patient outcomes and transform the standard of care in urology.

Neonc Technologies, Inc. is an early-stage cancer biotechnology company that specializes in the development of innovative delivery methods for novel, highly purified monoterpenes, derived from fruits and plants. The company is initially focusing on the treatment of malignant brain cancers, specifically gliomas, through intranasal inhalation and other nontraditional delivery methods. As part of its research, Neonc is developing several proprietary molecules, with some showing significant efficacy in laboratory tests. The company aims to build a robust portfolio of intellectual property surrounding its research initiatives. Neonc is also advancing its lead product, NEO100, which has entered Phase 2a clinical trials for glioblastoma and has received Orphan Drug and Fast Track designations from the FDA. Furthermore, Neonc has established a partnership with a manufacturer for the production of its proprietary monoterpenes, reinforcing its commitment to innovative cancer therapies.

Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

XLD is a decentralized fintech company focused on providing financial services to emerging markets. By leveraging blockchain technology, XLD aims to modernize the infrastructure of financial services, enabling users to access simple and reliable financial tools. The platform facilitates the spendability of cryptocurrency, allowing clients to earn tokens and convert their digital assets into fiat currency and other practical applications. Through its inclusive approach, XLD seeks to empower individuals in underserved regions, promoting financial development and accessibility.

ZiO Health is a biotechnology company focused on enhancing patient outcomes through its innovative pocket-sized laboratory testing technology. The company has developed proprietary biosensor devices that utilize machine learning algorithms to provide real-time results tailored to individual patient profiles. These multi-functional electronic devices are designed for measuring, testing, and detecting the molecular composition of various chemical and biological substances, enabling users to assess the presence, absence, or quantity of specific target molecules. By delivering quality home diagnostics and personalized testing solutions, ZiO Health aims to empower individuals to optimize their health and prevent illness.

Dora Maar is an online retailer specializing in designer apparel and accessories for women. The company operates an e-commerce platform that focuses on pre-owned luxury fashion, allowing consumers to explore a curated selection of items sourced from the closets of influential tastemakers and consignors. Customers can shop for a variety of products, including dresses, tops, jackets, skirts, jumpsuits, bags, shoes, and accessories. By connecting consumers with a network of women inspired by personal style and intentional fashion choices, Dora Maar facilitates a unique shopping experience that emphasizes sustainability and individuality in fashion.

Backer is a prominent fintech company specializing in 529 college savings plans, aimed at simplifying the process of saving for education. The company offers an investment platform that enables families to establish college savings plans efficiently, facilitating contributions from family and friends. Its user-friendly gifting platform and innovative mobile application enhance the experience by allowing for seamless tax-free investments. Backer's strategic partnerships with various 529 programs further bolster its high enrollment conversion rates, distinguishing it in the education savings market. The company's focus on making education savings accessible and straightforward supports families in planning for their children's educational futures.

Dora Maar is an online retailer specializing in designer apparel and accessories for women. The company operates an e-commerce platform that focuses on pre-owned luxury fashion, allowing consumers to explore a curated selection of items sourced from the closets of influential tastemakers and consignors. Customers can shop for a variety of products, including dresses, tops, jackets, skirts, jumpsuits, bags, shoes, and accessories. By connecting consumers with a network of women inspired by personal style and intentional fashion choices, Dora Maar facilitates a unique shopping experience that emphasizes sustainability and individuality in fashion.

nFlux AI is a developer of an artificial general intelligence platform focused on enhancing human capabilities through advanced technology. The company specializes in computer vision operations, providing intelligent video analytics that automate the extraction of contextual insights from unstructured data within video footage. This innovative approach allows clients to leverage proprietary machine comprehension services, enabling a deeper understanding of their data. nFlux's first significant collaboration was with NASA, where the company was tasked with creating a cognitive architecture to support deep space missions, allowing intelligent systems to assist astronauts autonomously when communication with Earth is not feasible. The company's vision is to advance intelligence in ways that positively impact humanity, supported by investments from prominent organizations and venture capital firms.

The SpringHill Company LLC is a media and entertainment firm based in Los Angeles, California, that specializes in brand development and management. Incorporated in 2020, it focuses on producing a diverse range of content, including feature films, television series, and digital media. The company consists of several divisions, notably SpringHill Entertainment, Uninterrupted, and The Robot Company, each contributing to its mission of creating compelling narratives. In addition to content creation, The SpringHill Company offers event management services and consultancy to media partners, aimed at delivering competitive and innovative solutions in storytelling across various platforms.

ArsenalBio is a programmable cell therapy company established in 2019, focused on developing and commercializing innovative immune cell therapies, particularly for cancer treatment. The company utilizes advanced technologies, including CRISPR-based genome engineering, synthetic biology, and machine learning, to create multifunctional T-cell therapies. ArsenalBio's approach involves the precise insertion of large synthetic DNA sequences, enabling the generation of next-generation autologous T-cell therapies. By integrating these cutting-edge methods, ArsenalBio aims to enhance the effectiveness and safety of immune cell therapies, reduce costs for healthcare providers, and improve market access, ultimately broadening patient outcomes and making these therapies more widely available.

Sensfix B.V., founded in 2018 and based in Amsterdam, develops a technology-agnostic platform designed for asset management across various infrastructure applications, such as streetlights, buildings, bank ATMs, and city gas systems. Its IoT-connected platform allows machines to autonomously schedule and manage their repair and maintenance needs while ensuring transparent decision-making among all stakeholders. By digitizing workflows and implementing a machine-initiated real-time ticketing system, Sensfix aims to enhance the efficiency of operations. The platform leverages IoT sensors to facilitate instantaneous connections between assets, owners, and service personnel, enabling self-scheduling, self-dispatch, and self-ticketing services. This enterprise SaaS solution is reported to reduce the operational and maintenance costs of physical assets by 30% and achieve a repair success rate on the first visit while minimizing repair failures to less than 1%.

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

Samay is a developer of an innovative AI-enabled wearable device focused on remote respiratory health management. The company addresses the growing need for effective chronic obstructive pulmonary disease (COPD) diagnostics and management, projected to incur significant healthcare costs in the coming years. Their patented chest patches provide passive monitoring of lung function, achieving 90% accuracy in COPD diagnosis and 83% accuracy in detecting exacerbation biomarkers. The device continuously tracks vital respiratory metrics, including pulmonary volumes, heart rates, and breathing sounds for two weeks, offering users valuable insights to optimize their respiratory health. Additionally, Samay is creating an AI-assisted management platform that supports patients and healthcare providers throughout the care continuum, enhancing personalized care from the comfort of home.

Licious is an innovative company in the Indian food industry focused on addressing the ongoing challenge of providing safe and high-quality fresh meat. It operates an online meat delivery platform that offers a variety of meat products, including fresh chicken, lamb, and seafood. Licious ensures that its products are carefully procured, processed, and stored, allowing consumers to conveniently receive fresh meat delivered directly to their homes. By enhancing the procurement and consumption of meat in India, Licious aims to transform the way meat is sourced and enjoyed by consumers across the country.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative gene therapy treatments for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes advanced oral lipid nanoparticle technology to deliver mRNA and plasmid DNA directly to intestinal stem cells. This approach aims to address the root causes of gastrointestinal diseases, including Familial Adenomatous Polyposis (FAP), a hereditary condition that can lead to colorectal cancer and often necessitates invasive surgical interventions. DNALite's therapies seek to transform protein biologics into oral drugs, allowing for more effective and less invasive treatment options.

BetterPet, Inc. was established with one mission in mind: Improve the lives of pets and their owners everywhere. With the rise of mobile phones, tablets, and a vast array of ever-evolving digital technologies, why should we humans have all the fun? We create products that strengthen the bond between people and their pets and that connect the community of animal lovers worldwide.